.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Canna Dots has recently made notable strides in the New York market, particularly within the Tincture & Sublingual category. After not appearing in the top 30 rankings from September to November 2025, Canna Dots surged to the 12th position by December. This upward movement indicates a significant boost in their market presence and consumer interest in this product category. Although specific sales figures for the months leading up to December are not available, the December sales figure of $11,475 suggests a strong performance that likely contributed to their improved ranking.
While the performance in New York shows promising growth, it's important to note that Canna Dots did not rank in the top 30 in the preceding months. This absence could imply either a late entry into the market or a strategic shift that paid off towards the end of the year. Such dynamics highlight the competitive nature of the cannabis market in New York and the potential for rapid changes in brand standings. Observing how Canna Dots capitalizes on this momentum in the coming months will be crucial for understanding their long-term strategy and positioning in the Tincture & Sublingual category.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Canna Dots has made a notable entry in December 2025, ranking 12th. This is significant as it marks the brand's debut in the top 20, indicating a potential upward trajectory in market presence. In contrast, Harney Brothers Cannabis has shown consistent improvement, climbing from 11th in September to 8th by December, with a steady increase in sales. Meanwhile, Canna Clinicals experienced fluctuations, dropping to 11th in November but recovering to 9th in December. Jumbodose and Chime & Chill have seen a decline in ranks, with Jumbodose falling out of the top 20 by December. This dynamic environment suggests that while Canna Dots is gaining ground, it faces stiff competition from established brands like Harney Brothers Cannabis, which are strengthening their market positions.
Notable Products
In December 2025, Canna Dots' top-selling product was Orange Sublingual Dots 20-Pack (100mg) in the Tincture & Sublingual category, maintaining its first-place position from previous months with sales reaching 130 units. Cherry Sublinguals Dots 20-Pack (100mg) also showed strong performance, climbing to the second rank from third in November, with notable sales of 124 units. Unflavored Sublinguals 40-Pack (100mg) dropped to third place after briefly holding the second spot in November. Blueberry Sublinguals Dots 20-Pack (100mg) remained consistent at fourth place, mirroring its October ranking despite a sales increase. Overall, December saw a solid performance across the top products, with some shifts in rankings that highlight changing consumer preferences within the Tincture & Sublingual category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
